These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19609949)

  • 1. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
    Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
    Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
    Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
    Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
    Lindroth Y; Pedersen L; Alssamaray J; Berglund T; Sundqvist A; Borgfeldt C; Forslund O
    Acta Obstet Gynecol Scand; 2024 Feb; 103(2):378-386. PubMed ID: 37964497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
    Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel DNA methylation markers in cervical cancer.
    Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
    Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Kweon SS; Fackler MJ; Sukumar S
    Virchows Arch; 2010 Jul; 457(1):35-42. PubMed ID: 20496080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy.
    Lu Y; Wu H; Fu K; Shen Y; Li L; Liao Z; Liu Y; Kang Y; Zhang Y
    Clin Epigenetics; 2024 Jun; 16(1):77. PubMed ID: 38849868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of
    Molano M; Machalek DA; Tan G; Garland S; Balgovind P; Haqshenas G; Munnull G; Phillips S; Badman SG; Bolnga J; Cornall AM; Gabuzzi J; Kombati Z; Brotherton J; Saville M; Hawkes D; Kaldor J; Toliman PJ; Vallely AJ; Murray GL
    BMJ Open; 2024 Jun; 14(6):e081282. PubMed ID: 38904134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical detection of raf kinase inhibitor protein and human papillomavirus profiling of normal and abnormal cervical ThinPrep samples.
    Al-Awadhi R; Husain S; Chehadeh W; Al-Jassar W; Kapila K; Al-Mulla F
    Acta Cytol; 2013; 57(3):259-65. PubMed ID: 23636063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
    Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
    Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.
    Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB
    Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
    Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
    Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting.
    Padalko E; Ali-Risasi C; Mesmaekers S; Ryckaert I; Van Renterghem L; Lambein K; Bamelis M; De Mey A; Sturtewagen Y; Vastenavond H; Broeck DV; Weyers S; Praet M
    Eur J Cancer Prev; 2015 Sep; 24(5):447-53. PubMed ID: 25370681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
    Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
    Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.